
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | $8.4M | $13.3M | $51.9M | $105.6M | $129.8M | |
Selling, General & Admin | $1.2M | $2.5M | $26.7M | $23.1M | $26.5M | |
Other Inc / (Exp) | -$34K | -$2.5M | -$96.2M | -$1.5M | $19.5M | |
Operating Expenses | $9.6M | $15.8M | $78.5M | $128.7M | $156.4M | |
Operating Income | -$9.6M | -$15.8M | -$78.5M | -$128.7M | -$156.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -$9.6M | -$18.3M | -$173.1M | -$126.1M | -$137.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $933K | $1.6M | $507K | |
Net Income to Company | -$9.6M | -$18.3M | -$174M | -$127.7M | -$138.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$9.6M | -$18.3M | -$174M | -$127.7M | -$138.2M | |
Basic EPS (Cont. Ops) | -$0.04 | -$0.07 | -$0.68 | -$0.46 | -$0.48 | |
Diluted EPS (Cont. Ops) | -$0.04 | -$0.07 | -$0.68 | -$0.46 | -$0.48 | |
Weighted Average Basic Share | $264.3M | $264.3M | $254.1M | $275.8M | $288.5M | |
Weighted Average Diluted Share | $264.3M | $264.3M | $254.1M | $275.8M | $288.5M | |
EBITDA | -$9.6M | -$18.1M | -$173.1M | -$125.7M | -$133.7M | |
EBIT | -$9.6M | -$18.3M | -$173.1M | -$125.8M | -$134M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -$9.6M | -$15.8M | -$78.5M | -$128.7M | -$156.4M | |
Operating Income (Adjusted) | -$9.6M | -$18.3M | -$173.1M | -$125.8M | -$134M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $9.1M | $21.5M | $27.5M | $44.7M | |
Selling, General & Admin | -- | $808.8K | $6.2M | $6.5M | $7.9M | |
Other Inc / (Exp) | -- | -$86.6K | $1.1M | $8.4M | $5.5M | |
Operating Expenses | -- | $9.9M | $27.7M | $33.9M | $52.6M | |
Operating Income | -- | -$9.9M | -$27.7M | -$33.9M | -$52.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$10M | -$25.6M | -$24.7M | -$49.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $174K | $623K | -$558K | |
Net Income to Company | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Basic EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.09 | -$0.16 | |
Diluted EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.09 | -$0.16 | |
Weighted Average Basic Share | -- | $264.3M | $275.5M | $276.3M | $303.6M | |
Weighted Average Diluted Share | -- | $264.3M | $275.5M | $276.3M | $303.6M | |
EBITDA | -- | -$9.9M | -$25.6M | -$24.2M | -$47M | |
EBIT | -- | -$9.9M | -$25.6M | -$24.3M | -$47.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$9.9M | -$27.7M | -$33.9M | -$52.6M | |
Operating Income (Adjusted) | -- | -$9.9M | -$25.6M | -$24.3M | -$47.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $20.5M | $64.3M | $111.5M | $147.1M | |
Selling, General & Admin | -- | $3M | $32M | $23.4M | $27.9M | |
Other Inc / (Exp) | -- | -$2.3M | -$94.9M | $5.8M | $16.5M | |
Operating Expenses | -- | $23.5M | $96.3M | $134.9M | $175M | |
Operating Income | -- | -$23.5M | -$96.3M | -$134.9M | -$175M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$25.8M | -$188.7M | -$125.2M | -$162.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $1.1M | $2M | -$674K | |
Net Income to Company | -- | -- | -$189.8M | -$127.2M | -$161.7M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$25.8M | -$189.8M | -$127.2M | -$161.7M | |
Basic EPS (Cont. Ops) | -- | -$0.10 | -$0.72 | -$0.45 | -$0.55 | |
Diluted EPS (Cont. Ops) | -- | -$0.10 | -$0.72 | -$0.45 | -$0.55 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -$27.2M | -$188.7M | -$124.3M | -$156.6M | |
EBIT | -- | -$27.3M | -$188.8M | -$124.5M | -$156.8M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$23.5M | -$96.3M | -$134.9M | -$175M | |
Operating Income (Adjusted) | -- | -$27.3M | -$188.8M | -$124.5M | -$156.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | $9.1M | $21.5M | $27.5M | $44.7M | |
Selling, General & Admin | -- | $808.8K | $6.2M | $6.5M | $7.9M | |
Other Inc / (Exp) | -- | -$86.6K | $1.1M | $8.4M | $5.5M | |
Operating Expenses | -- | $9.9M | $27.7M | $33.9M | $52.6M | |
Operating Income | -- | -$9.9M | -$27.7M | -$33.9M | -$52.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -$10M | -$25.6M | -$24.7M | -$49.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | $174K | $623K | -$558K | |
Net Income to Company | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Basic EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.09 | -$0.16 | |
Diluted EPS (Cont. Ops) | -- | -$0.04 | -$0.09 | -$0.09 | -$0.16 | |
Weighted Average Basic Share | -- | $264.3M | $275.5M | $276.3M | $303.6M | |
Weighted Average Diluted Share | -- | $264.3M | $275.5M | $276.3M | $303.6M | |
EBITDA | -- | -$9.9M | -$25.6M | -$24.2M | -$47M | |
EBIT | -- | -$9.9M | -$25.6M | -$24.3M | -$47.1M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -$9.9M | -$27.7M | -$33.9M | -$52.6M | |
Operating Income (Adjusted) | -- | -$9.9M | -$25.6M | -$24.3M | -$47.1M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | $14.4M | $49.1M | $46.9M | $56.4M | |
Short Term Investments | -- | -- | $178.8M | $111.2M | $247M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $1.9K | $17.1K | -- | $824K | $8.7M | |
Other Current Assets | $2.2K | $4.1K | $1.4M | $64K | $258K | |
Total Current Assets | $49.6K | $20.9M | $312.2M | $242.2M | $312.8M | |
Property Plant And Equipment | -- | -- | $668K | $1.1M | $1.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $23.4K | $699.8K | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | $348K | $1.1M | |
Total Assets | $73K | $21.6M | $312.9M | $245.3M | $318.2M | |
Accounts Payable | $847K | $877.6K | $2.1M | $4.6M | $1.1M | |
Accrued Expenses | $199.3K | -- | -- | $11.8M | $13.8M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | $32.2K | $3.6M | $14M | $7M | |
Total Current Liabilities | $1M | $10.2M | $24.9M | $52M | $59.3M | |
Long-Term Debt | -- | -- | -- | $25.8M | $132M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1M | $10.9M | $26M | $80.3M | $194.3M | |
Common Stock | -$1.1M | $220K | $269K | $269K | $298K | |
Other Common Equity Adj | $45.4K | -$32.2K | -- | -- | -- | |
Common Equity | -$1M | $10.7M | $286.9M | $165.1M | $123.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -$1M | $10.7M | $286.9M | $165.1M | $123.9M | |
Total Liabilities and Equity | $73K | $21.6M | $312.9M | $245.3M | $318.2M | |
Cash and Short Terms | -- | $14.4M | $227.9M | $158.1M | $303.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $11.8M | $23.6M | $59.5M | |
Short Term Investments | -- | -- | $199.1M | $114.7M | $228.1M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | $699.6K | -- | -- | |
Other Current Assets | -- | -- | $41.1K | $1.6M | $10M | |
Total Current Assets | -- | -- | $295.5M | $224.3M | $297.6M | |
Property Plant And Equipment | -- | -- | $801.5K | $1.5M | $1.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | $811K | $1.9M | |
Total Assets | -- | -- | $296.3M | $228.3M | $304.2M | |
Accounts Payable | -- | -- | $490.2K | $1.6M | $663K | |
Accrued Expenses | -- | -- | -- | -- | $23.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | $129K | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | $5.8M | $7.6M | $3.7M | |
Total Current Liabilities | -- | -- | $32.9M | $45.2M | $82.7M | |
Long-Term Debt | -- | -- | -- | $40M | $142.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $33.8M | $87.4M | $228M | |
Common Stock | -- | -- | $269.1K | $269K | $298K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | $262.5M | $140.9M | $76.1M | |
Total Liabilities and Equity | -- | -- | $296.3M | $228.3M | $304.2M | |
Cash and Short Terms | -- | $12.5M | $211M | $138.3M | $287.6M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$9.6M | -$18.3M | -$174M | -$127.7M | -$138.2M | |
Depreciation & Amoritzation | $9.1K | $108K | $25K | $184K | $252K | |
Stock-Based Compensation | -- | $150K | $3.3M | $3.3M | $3.7M | |
Change in Accounts Receivable | -- | -$220K | -$3.2M | -$126K | -$2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$9M | -$14.9M | -$59.5M | -$94.5M | -$136M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$258.5M | $66.8M | -$56.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$1.4M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $25.5M | $110.8M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | $9M | $29.3M | $354.1M | -$530K | -$2M | |
Cash From Financing | $9M | $29.3M | $352.7M | $24.9M | $203M | |
Beginning Cash (CF) | -- | -- | $14.4M | $49.1M | $46.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $14.4M | $34.8M | -$2.8M | $10.8M | |
Ending Cash (CF) | -- | $14.4M | $49.1M | $46.9M | $56.4M | |
Levered Free Cash Flow | -$9M | -$14.9M | -$59.9M | -$94.7M | -$141.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Depreciation & Amoritzation | -- | -- | $22K | $51K | $82K | |
Stock-Based Compensation | -- | -- | $868K | $1.1M | $1M | |
Change in Accounts Receivable | -- | $57.3K | -$3.7M | -$2.5M | $420K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$1.9M | -$19.9M | -$35.8M | -$24.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$17.5M | -$2.1M | $18.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $15M | $9.5M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$219K | -$178K | |
Cash From Financing | -- | -- | -- | $14.7M | $9.3M | |
Beginning Cash (CF) | -- | $14.4M | $49.1M | $46.9M | $56.4M | |
Foreign Exchange Rate Adjustment | -- | -- | $126K | -$122K | $209K | |
Additions / Reductions | -- | -$1.9M | -$37.4M | -$23.2M | $2.9M | |
Ending Cash (CF) | -- | $12.5M | $11.8M | $23.6M | $59.5M | |
Levered Free Cash Flow | -- | -$1.9M | -$19.9M | -$35.9M | -$25.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$189.8M | -$127.2M | -$161.7M | |
Depreciation & Amoritzation | -- | -- | $47K | $213K | $283K | |
Stock-Based Compensation | -- | -- | $4.2M | $3.6M | $3.6M | |
Change in Accounts Receivable | -- | -- | -$7M | $1.1M | $899K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$77.5M | -$110.4M | -$125M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$276M | $82.3M | -$35.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -$1.4M | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $40.4M | $105.3M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$749K | -$2M | |
Cash From Financing | -- | -- | $352.7M | $39.7M | $197.5M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$797.1K | $11.5M | $36.9M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -$77.5M | -$110.7M | -$130.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$10M | -$25.8M | -$25.3M | -$48.8M | |
Depreciation & Amoritzation | -- | -- | $22K | $51K | $82K | |
Stock-Based Compensation | -- | -- | $868K | $1.1M | $1M | |
Change in Accounts Receivable | -- | $57.3K | -$3.7M | -$2.5M | $420K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$1.9M | -$19.9M | -$35.8M | -$24.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -$17.5M | -$2.1M | $18.5M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $15M | $9.5M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -$219K | -$178K | |
Cash From Financing | -- | -- | -- | $14.7M | $9.3M | |
Beginning Cash (CF) | -- | $14.4M | $49.1M | $46.9M | $56.4M | |
Foreign Exchange Rate Adjustment | -- | -- | $126K | -$122K | $209K | |
Additions / Reductions | -- | -$1.9M | -$37.4M | -$23.2M | $2.9M | |
Ending Cash (CF) | -- | $12.5M | $11.8M | $23.6M | $59.5M | |
Levered Free Cash Flow | -- | -$1.9M | -$19.9M | -$35.9M | -$25.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.